KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+5.77%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$198M
AUM Growth
+$198M
(+5.4%)
Cap. Flow
+$1.02M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
99.63%
Holding
17
New
6
Increased
2
Reduced
–
Closed
4
Top Buys
| 1 |
Theriva Biologics
TOVX
|
$2.05M |
| 2 |
Arcturus Therapeutics
ARCT
|
$1.8M |
| 3 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$1.3M |
| 4 |
Inovio Pharmaceuticals
INO
|
$1.17M |
| 5 |
ADXS
Advaxis, Inc.
ADXS
|
$947K |
Top Sells
| 1 |
VVUS
Vivus Inc
VVUS
|
$4.65M |
| 2 |
Genworth Financial
GNW
|
$2.7M |
| 3 |
CELG
Celgene Corp
CELG
|
$225K |
| 4 |
Exact Sciences
EXAS
|
$165K |
Sector Composition
| 1 | Healthcare | 18.06% |
| 2 | Technology | 0.46% |
| 3 | Financials | 0% |